Interestingly, that stromal expression of SPARC and SPP1 was prognostic for the reduced RFS and PFS, respectively, only in rectal cancer patients, while S100A4 correlated with poor OS rates in CRC and colon cancer patients. Here, SPP1 is linked to colonic neoplasm.